The in vivo conversion of CBD to Δ9-THC is not supported by the majority of human or animal studies, investigators concluded.
Region: Germany
At 20 months, the subject reported an improvement of compulsions and obsessions of more than 90 percent.
Consistent with the findings of other recent studies, authors reported. “[N]o conversion of CBD to THC was observed in any of the samples.”
Hannover, Germany: The use of cannabis and cannabinoids is associated with subjective benefits in patients…
Munich, Germany: The administration of cannabinoid-infused oils containing THC and CBD is associated with symptomatic…
Potsdam, Germany: The administration of oral THC (dronabinol) safely and effectively reduces pain in geriatric…
Düsseldorf, Germany: The presence of low levels of THC in blood is poorly correlated with…
The adjunctive use of cannabidiol is associated with a remission in schizophrenic symptoms in a patient previously unresponsive to conventional treatment.